Increased incidence of liver cancer after successful DAA treatment of chronic hepatitis C: Fact or fiction?

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

(2017) Pierre Nahon et al.   GASTROENTEROLOGY

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

(2017) Adriaan J. van der Meer et al.   JOURNAL OF HEPATOLOGY

Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

(2017) Claudio Zavaglia et al.   JOURNAL OF HEPATOLOGY

A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma

(2017) Giuseppe Cabibbo et al.   LIVER INTERNATIONAL

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

(2016) S. Petta et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection

(2016) Hashem B. El-Serag et al.   HEPATOLOGY

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

(2016) Fabio Conti et al.   JOURNAL OF HEPATOLOGY

Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma

(2016) Ju Dong Yang et al.   JOURNAL OF HEPATOLOGY

High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis

(2016) Helder Cardoso et al.   JOURNAL OF HEPATOLOGY

Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing

(2016) Calogero Cammà et al.   JOURNAL OF HEPATOLOGY

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

(2016) María Reig et al.   JOURNAL OF HEPATOLOGY

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

(2016) Michelle C.M. Cheung et al.   JOURNAL OF HEPATOLOGY

Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts

(2016)   JOURNAL OF HEPATOLOGY

Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population

(2016) Savino Bruno et al.   JOURNAL OF HEPATOLOGY

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

(2016) Michael Manns et al.   LANCET INFECTIOUS DISEASES

Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis

(2016) Toshifumi Tada et al.   LIVER INTERNATIONAL

Effect of HCV clearance with direct-acting antiviral agents on HCC

(2016) Josep M. Llovet et al.   Nature Reviews Gastroenterology & Hepatology

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes

(2015) Hamish A. Innes et al.   HEPATOLOGY

New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges

(2014) Jean–Michel Pawlotsky   GASTROENTEROLOGY

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

(2013) Rebecca L. Morgan et al.   ANNALS OF INTERNAL MEDICINE